Mercaptopyruvate inhibits tissue-nonspecific alkaline phosphatase and calcium pyrophosphate dihydrate crystal dissolution

Journal of Rheumatology

Volumn 36, Issue 12, 2009, Pages 2758-2765

  Kannampuzha, Jovil V A ^a   Tupy, Jindra H ^a   Pritzker, Kenneth P H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alkaline phosphatase; Amino acids; Arthritis; Calcium pyrophosphate; Cartilage; Mercaptopyruvate

Indexed keywords

ALKALINE PHOSPHATASE; AMINO ACID; CALCIUM PYROPHOSPHATE; CYSTEINE; MERCAPTOPYRUVATE; PYRUVIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTHROPATHY; ARTICLE; CALCIUM PYROPHOSPHATE DIHYDRATE CRYSTAL DEPOSITION DISEASE; CARTILAGE; CRYSTAL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; PRIORITY JOURNAL; PSEUDOGOUT;

ALKALINE PHOSPHATASE; CALCIUM PYROPHOSPHATE; CHONDROCALCINOSIS; CYSTEINE; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE;

EID: 72449201714     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090098     Document Type: Article

References (47)

1. +], and ionic strength determined from equilibrium studies of the reaction. J Biol Chem 1974;249:3465-3473
2. Van Wazer JR, Griffith EJ, McCullough JF. Structure and properties of the condensed phosphates. VII. Hydrolytic degradation of pyro- and tripolyphosphate. J Am Chem Soc 1955;77:287-291
3. Bennett RM, Lehr JR, McCarty DJ. Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. J Clin Invest 1975;56:1571-1579
4. Xu Y, Cruz TF, Cheng P-T, Pritzker KPH. Effects of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1991;18:66-71.
5. Xu Y, Cruz TF, Pritzker KPH. Alkaline phosphatase dissolves calcium pyrophosphatase dihydrate crystals. J Rheumatol 1991;18:1606-1610
6. Xu Y, Pritzker KPH, Cruz TF. Characterization of chondrocyte alkaline phosphatase as a mediator in the dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1994;21:912-919 (Pubitemid 24168678)
7. Rees JA, Ali SY. Ultrastructural localization of alkaline phosphatase activity in osteoarthritic human articular cartilage. Ann Rheum Dis 1988;47:747-753 (Pubitemid 18220968)
8. Pfander D, Swoboda B, Kirsch T. Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes. Am J Pathol 2001;159:1777-1783 (Pubitemid 33062520)
9. Fishman WH, Sie HG. Organ-specific inhibition of human alkaline phosphatase isoenzymes of liver, bone, intestine and placenta; L-phenylalanine, L-tryptophan and L-homoarginine. Enzymologia 1971;41:141-167
10. Bodansky O. The inhibitory effects of DL-alanine, L-glutamic acid, L-lysine, and L-histidine on the activity of intestinal, bone and kidney phosphatases. J Biol Chem 1948;174:465-476
11. Brunel C, Cathala G. Imidazole: an inhibitor of L-phenylalanine- insensitive alkaline phosphatases of tissues other than intestine and placenta. Biochim Biophys Acta 1972;268:415-421
12. Agus SG, Cox RP, Griffin MJ. Inhibition of alkaline phosphatase by cysteine and its analogues. Biochim Biophys Acta 1966;118:363-370
13. Cox RP, Gilbert P Jr, Griffin MJ. Alkaline inorganic pyrophosphatase activity of mammalian-cell alkaline phosphatase. Biochem J 1967;105:155-161
14. Griffin MJ, Cox C. Studies on the mechanism of substrate induction and L-cysteine repression of alkaline phosphatase in mammalian cell cultures. J Cell Sci 1967;2:545-555
15. So PP, Tsui FW, Vieth R, Tupy JH, Pritzker KP. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol 2007;34:1313-1322 (Pubitemid 46898114)
16. Nagahara N, Sawada N. The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase. Curr Med Chem 2006;13:1219-1230
17. Kyoto encyclopedia of genes and genomes. Cysteine metabolism. [Internet. Accessed xxxx.] Available from: wwwgenomejp/dbget-bin/get-pathway?org-name= ko&mapno=00272 2009.
18. Cheng P-T, Pritzker KPH, Adams ME, Nyburg SC, Omar SA. Calcium pyrophosphate crystal formation in aqueous solutions. J Rheumatol 1980;7:609-616 (Pubitemid 11160455)
19. m in enzyme reactions. Science 1952;116:329-331
20. Kirsch PD, Ekerdt JG. KaleidaGraph: graphing and data analysis. Version 3.5 for Windows. Computer software reviews. J Am Chem Soc 2000;122:11755.
21. Hase M. KaleidaGraph 3.0.5. for MacIntosh and Windows. Computer software reviews. J Am Chem Soc 1997;119:4323.
22. Tommasini R, Endrenyi L, Taylor PA, Mahuran DJ, Lowden JA. A statistical comparison of parameter estimation for the Michaelis-Menten kinetics of human placental hexosaminidiase. Can J Biochem Cell Biology 1985;63:225-230 (Pubitemid 15072815)
23. Cortes A, Cascante M, Cardenas ML, Cornish-Bowden A. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J 2001;357:263-268 (Pubitemid 32642925)
24. Cornish-Bowden A. A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem J 1974;137:143-144
25. Cini R, Chindamo D, Catenaccio M, Lorenzini S, Selvi E, Nerucci F, et al. Dissolution of calcium pyrophosphate crystals by polyphosphates: an in vitro and ex vivo study. Ann Rheum Dis 2001;60:962-967 (Pubitemid 32885672)
26. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 2005;10:822-837
27. Millan JL. Alkaline phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2006;2:335-341
28. Millan JL. APs as therapeutic agents. Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2006:227-236
29. Millan JL. The in vivo role of TNAP. Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2006:107-129
30. Shinozaki T, Xu Y, Cruz TF, Pritzker KPH. Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals. J Rheumatol 1995;22:117-123
31. Coleman JE. Structure and mechanism of alkaline phosphatase. Ann Rev Biophys Biomol Struct 1992;21:441-483
32. Kim EE, Wyckof H. Structure of alkaline phosphatases. Clin Chim Acta 1990;186:175-187
33. Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Arthritis Rheum 1992;22:188-202.
34. McKenna M, Hamilton T, Sussman H. Comparison of human alkaline phosphatase isoenzymes. Structural evidence for three protein classes. Biochem J 1979;181:67-73.
35. Cooper AJL. Biochemistry of sulfur-containing amino acids. Ann Rev Biochem 1983;52:187-222.
36. McNearney T, Speegle D, Lawand NB, Lisse J, Westlund KN. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 2000;27:739-745 (Pubitemid 30151357)
37. Fernstrom J, Wurtman R, Hammarstrom-Wiklund B, Rand W, Munro H, Davidson C. Diurnal variations in plasma concentrations of tryptophan, tyrosine, and other neutral amino acids: Effect of dietary protein intake. Am J Clin Nutr 1979;32:1912-1922 (Pubitemid 10220306)
38. Hunter GK, Grynpas MD, Cheng P-T, Pritzker KPH. Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels. Calcif Tissue Int 1987;41:164-170
39. Brigham MP, Stein WH, Moore S. The concentrations of cysteine and cystine in human blood plasma. J Clin Invest 1960;39:1633-1638
40. Klassen P, Furst P, Schulz C, Mazariegos M, Solomons NW. Plasma free amino acid concentrations in healthy Guatemalan adults and in patients with classic dengue. Am J Clin Nutr 2001;73:647-652 (Pubitemid 32176518)
41. Lepage N, McDonald N, Dallaire L, Lambert M. Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem 1997;43:2397-2402 (Pubitemid 28022978)
42. Ravaglia G, Forti P, Maioli F, Bianchi G, Sacchetti L, Talerico T, et al. Plasma amino acid concentrations in healthy and cognitively impaired oldest-old individuals: associations with anthropometric parameters of body composition and functional disability. Br J Nutr 2002;88:563-572
43. Wancket LM, Baragi V, Bove S, Kilgore K, Korytko PJ, Guzman RE. Anatomical localization of cartilage degradation markers in a surgically induced rat osteoarthritis model. Toxicol Pathol 2005;33:484-489 (Pubitemid 40995488)
44. Rafii M, Elango R, Courtney-Martin G, House JD, Fisher L, Pencharz PB. High-throughput and simultaneous measurement of homocysteine and cysteine in human plasma and urine by liquid chromatography-electrospray tandem mass spectrometry. Anal Biochem 2007;371:71-81. (Pubitemid 47538484)
45. Derfus B, Steinberg M, Mandel N, Buday M, Daft L, Ryan L. Characterization of an additional articular cartilage vesicle fraction that generates calcium pyrophosphate dihydrate crystal in vitro. J Rheumatol 1995;22:1514-1519
46. Derfus BA, Rachow JW, Mandel NS, Boskey AL, Buday M, Kushnaryov VM, et al. Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. Arthritis Rheum 1992;35:231-240
47. Ryan LM, Kurup I, Rosenthal AK, McCarty DJ. Stimulation of inorganic pyrophosphate elaboration by cultured cartilage and chondrocytes. Arch Biochem Biophys 1989;272:393-399 (Pubitemid 19183553)